Wolverine Trading, LLC
- SEC CIK
- 0000927337
- Latest filing
- Nov 14, 2025
AZN holding history
AstraZeneca PLC in every 13F filed by Wolverine Trading, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
AZN overviewAll 13F holders of AZNFull Q3 2025 holdings
- Shares (Q3 2025)
- 17,192
- Value
- $1.27M
- % of portfolio
- <0.1%
- Quarters held
- 15
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2025 | 17,192 | $1.27M | <0.1% | +17,192 | New | Holders |
| Q2 2025 | 0 | $0 | 0.0% | −74,174−100.0% | Sold out | Holders |
| Q1 2025 | 74,174 | $5.47M | 0.2% | +62,192+519.0% | Added | Holders |
| Q4 2024 | 11,982 | $785.7K | <0.1% | +6,277+110.0% | Added | Holders |
| Q3 2024 | 5,705 | $442.8K | <0.1% | +2,608+84.2% | Added | Holders |
| Q2 2024 | 3,097 | $241.5K | <0.1% | −19,586−86.3% | Reduced | Holders |
| Q1 2024 | 22,683 | $1.54M | <0.1% | +12,338+119.3% | Added | Holders |
| Q4 2023 | 10,345 | $696.7K | <0.1% | −42,230−80.3% | Reduced | Holders |
| Q3 2023 | 52,575 | $3.56M | <0.1% | +52,575 | New | Holders |
| Q2 2023 | 0 | $0 | 0.0% | −39,429−100.0% | Sold out | Holders |
| Q1 2023 | 39,429 | $2.73M | 0.1% | +10,366+35.7% | Added | Holders |
| Q4 2022 | 29,063 | $1.97M | <0.1% | +13,663+88.7% | Added | Holders |
| Q3 2022 | 15,400 | $846.0K | <0.1% | +10,351+205.0% | Added | Holders |
| Q2 2022 | 5,049 | $338.0K | <0.1% | −8,584−63.0% | Reduced | Holders |
| Q1 2022 | 13,633 | $915.0K | <0.1% | +13,633 | New | Holders |
| Q4 2021 | 0 | $0 | 0.0% | −28,954−100.0% | Sold out | Holders |
| Q3 2021 | 28,954 | $1.73M | <0.1% | +28,954 | New | Holders |
| Q2 2021 | 0 | $0 | 0.0% | −23,504−100.0% | Sold out | Holders |
| Q1 2021 | 23,504 | $1.17M | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.